News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor (World)
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 2/5/2016
Vitrolife (VITR.ST): Report On Operations 2015: Continued Profitable Growth 2/5/2016
Biostar Pharmaceuticals, Inc. (BSPM) To Effect Reverse Stock Split 2/5/2016
Phagelux Announces Expansion Capital And Other Updates 2/5/2016
GlaxoSmithKline (GSK) CEO Asks Investors to Give Him Three Years to Turn Around Consumer Health Unit Before Considering a Break Up 2/4/2016
Sinovac Biotech Ltd. (SVA) Announces Receipt of Competing Non-Binding "Going Private" Proposal 2/4/2016
Immunotec Announces Issuance Of Bonus Shares 2/3/2016
Shire (SHPG) Assigned Investment Grade Credit Ratings By Moody's And S&P 1/28/2016
Novartis AG (NVS) Taps Former Hospira CEO to Rescue Alcon (ACL) 1/28/2016
Teva (TEVA) Releases Innovation And Social Responsibility Highlights 1/25/2016
Apollo Therapeutics: Consortium Of World-Leading UK Universities And Global Pharmaceutical Companies Launch £40 Million Fund To Drive Therapeutic Innovation 1/25/2016
Where Pfizer (PFE)-Allergan (AGN) May Be 10 Years Down the Road 1/22/2016
Mindray Medical Announces Extraordinary General Meeting Of Shareholders 1/19/2016
BioAmber Inc. Announces Pricing Of $11.0 Million Public Offering 1/15/2016
BioAmber Inc. Announces Public Offering Of Common Stock 1/14/2016
VolitionRX Releases Annual Shareholder Update Letter 1/13/2016
Roche (RHHBY) is Favored Stock at J.P. Morgan Conference, Although Investors Remain Unmoved 1/12/2016
Tianyin Pharmaceutical Co, Inc. Received Acceptance Letter From NYSE MKT Regarding Its Plan Of Compliance With Continued Listing Requirements 1/12/2016
Covalon Technologies Ltd. Chairman Acquires Additional Shares And Warrants 1/11/2016
ESSA Pharma Announces Proposed US$15 Million Private Placement 1/6/2016
Oramed (ORMP)' Shareholder Letter 1/6/2016
The Board Of Directors Of BioTie Therapies Corp. Has Approved Two Year Incentive Plan For Employees 1/5/2016
BioTie Therapies Corp.:Issuance Of Shares Pursuant To Option And Equity Incentive Plans 1/5/2016
Dehaier Medical Announces The Results Of 2015 Annual General Meeting 12/31/2015
Orchid Pharma Stock Surges on U.S. FDA Inspection Report for TN Unit 12/31/2015
Cadila Healthcare Shares Plunge After FDA Warning 12/31/2015
Binational Industrial R&D Foundation To Invest $7.5 Million In 9 New Projects 12/30/2015
Mindray Medical Announced Shareholder Resolutions Post 2015 Annual General Meeting 12/30/2015
Toshiba in Talks to Sell Toshiba Medical Systems 12/29/2015
Galapagos (GLPG.BR) Receives Transparency Notification From Wellington Management Group LLP 12/28/2015
Anpac Bio-Medical Science Receives "Series B" Funding From Shanghai Zhangjiang Science & Technology Investment Corp & Private Insurance Investors 12/28/2015
TxCell Admitted To The SRD (Deferred Settlement Service) “Long-Only” 12/23/2015
AAIPharma Services / Cambridge Major Laboratories, Inc. Invests In DE Dietrich Agitated Filter Dryer To Improve Its Manufacturing Capabilities In Weert, The Netherlands 12/21/2015
ProNAi Therapeutics, Inc. Added To NASDAQ Biotechnology Index 12/18/2015
ESSA Pharma Announces Filing Of Preliminary Shelf Prospectus And Registration Statement 12/16/2015
Nuvo Research (NRI.TO) Announces Special Shareholder Meeting To Vote On Reorganization Of Nuvo Into Two Publicly Traded Companies 12/15/2015
Mr. James Mellon And Dr. Gregory Bailey ("Offerors") Announce Additional Shares In Portage Biotech 12/15/2015
Athenex Announces Recent Business Developments Including The Acquisition Of Comprehensive Drug Enterprises 12/14/2015
Concord Medical Services Holdings Limited (CCM) Declares Special Dividend 12/11/2015
ORYZON Genomics Announces Listing On Madrid Stock Exchange 12/10/2015
BrainStorm Cell Reschedules Corporate Update Conference Call To January 11, 2016 12/10/2015
SpineGuard Announces Its 2016 Financial Calendar 12/10/2015
Macrocure (MCUR) Announces Annual General Meeting Of Shareholder 12/9/2015
Mylan (MYL) Announces Pricing Of Senior Notes 12/7/2015
Tianyin Pharmaceutical Co, Inc. Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 12/3/2015
Karolinska Development AB Divests Its Holding In Athera Biotechnologies 12/3/2015
Medicure Inc. (MCU) Announces Grant Of Stock Options 11/30/2015
Nuvo Research (NRI.TO) Announces Acceleration Of Expiry Date Of Outstanding Warrants 11/30/2015
Hanger (HGR) Announces Amended And Restated Consent Solicitation 11/30/2015
ProQR Therapeutics B.V. (PRQR) Announces R&D Day And Provides Update On Innovation Portfolio 11/30/2015
Pfallergan Makes Pfizer (PFE) Teva (TEVA)'s Largest Shareholder 11/25/2015
Most Popular Big Pharma Stock in America is Israel's Teva (TEVA) 11/25/2015
WuXi PharmaTech (WX) Announces Shareholders' Approval Of Merger Agreement 11/25/2015
BioLight Announces Joint Investment In Ioptima Subsidiary 11/25/2015
AEterna Zentaris (AEZS) Announces Exercise Of Last Series B Warrants Covered By November 1, 2015 Agreement 11/24/2015
Ortho RTi Announces The Filing Of A Preliminary Prospectus 11/24/2015
Kitov Pharmaceuticals Holdings Announces Pricing Of U.S. Initial Public Offering And Nasdaq Listing 11/23/2015
Endo International (ENDP) Announces Conditional Redemption Of All $400,000,000 Aggregate Principal Amount Outstanding Of The Two Series Of 7.00% Senior Notes Due 2020 11/23/2015
Newron Pharmaceuticals (NWRN) Completes 5.4 Million USD/CHF Private Placement With U.S. Biotechnology/Healthcare Specialist Fund 11/20/2015
Mallinckrodt (MNK) Board Adds $500 Million To Company's Existing Share Repurchase Program 11/19/2015
AEterna Zentaris (AEZS) Announces Details And Implementation Of Share Consolidation To Regain NASDAQ Compliance 11/18/2015
Strongbridge Biopharma Provides Update On Corporate Progress 11/18/2015
Amatsigroup: Significant Events Of 2015 And Outlook For 2016 11/17/2015
Mesoblast (MSB.AX) Lists On Nasdaq 11/16/2015
AEterna Zentaris (AEZS) Announces Shareholder Approval Of Share Consolidation 11/16/2015
Mesoblast (MSB.AX) Announces Pricing Of Public Offering On Nasdaq 11/13/2015
Alcobra (ADHD) Prices Public Offering Of Ordinary Shares 11/13/2015
Alcobra (ADHD) Announces Proposed Public Offering Of Ordinary Shares 11/13/2015
Boehringer Ingelheim Hacks Its R&D Budget to $11.8 Billion and Turns Focus on Collaborations Instead 11/12/2015
LivaNova Provides Business Update 11/12/2015
Celsion (CLSN) Announces Dual Listing On The Tel Aviv Stock Exchange 11/12/2015
AEterna Zentaris (AEZS) Announces Exercise Of Series B Warrants 11/12/2015
AEterna Zentaris (AEZS) Urges Shareholders To Vote In Favor Of The Share Consolidation And Highlights Support From ISS And Glass Lewis 11/11/2015
Perrigo (PRGO) Reaffirms Views On Mylan (MYL)'s Inadequate Offer; Maintains Strong Recommendation Shareholders Not Tender 11/10/2015
Perrigo (PRGO) Responds to Misleading Statements 11/9/2015
Perrigo (PRGO) Issues Shareholder Letter 11/9/2015
Vascular Biogenics Ltd. Announces Closing Of $15 Million Underwritten Offering Of Ordinary Shares And Warrants 11/6/2015
Valeant (VRX) Issues Statement On Sales Of Company Stock 11/6/2015
BioAmber Inc. Announces Operational And Financial Results For Q3 2015 11/5/2015
Bloomage BioTech Announces Key Investment By GIC To Build Up The Aesthetic Medical Ecosystem In China 11/5/2015
Zealand Pharma  (ZEAL.CO) Is Ready To Take Next Steps In A Diligent Growth Strategy For Accelerated Value Creation: From Peptide To Patient 11/4/2015
VolitionRX Announces Third Quarter 2015 Financial Results And Business Update 11/4/2015
Big Meetings This Week with GlaxoSmithKline (GSK), Roche (RHHBY), Sanofi (SNY) Have Investors on Pins and Needles 11/3/2015
Vascular Biogenics Ltd. Announces Pricing Of $15 Million Underwritten Offering Of Ordinary Shares And Warrants 11/3/2015
AEterna Zentaris (AEZS) Announces Agreement to Exercise Substantially All Remaining Series B Warrants 11/2/2015
Perrigo (PRGO) Comments On Mylan (MYL)'s Presentation 11/2/2015
Lonza Group Ltd. (LZAGY.PK) Reports Positive Momentum In Q3 And Continues Path Of Stabilization 10/29/2015
Sanofi (SNY)'s New CEO to Deliver Revival Plan After Being Hit by Lagging Sales and Rumors of Boardroom Rows 10/29/2015
Pharming Group (PHGUF.PK) Release: Interim Report January - September 2015 10/28/2015
Circassia (CIR.L) Business Update 10/27/2015
Elder Pharmaceutical Ltd. Reaffirms Commitment To Clear All Dues By Raising Funds Through Asset Sale Or Debt Or Issue Of Equity 10/27/2015
Prominent Fund Manager Urges GlaxoSmithKline (GSK) to Break Up 10/27/2015
Nordic Nanovector ASA – MANDATORY NOTIFICATION OF TRADE 10/26/2015
Under Pressure, GlaxoSmithKline (GSK)'s CEO Shows Off Innovation and Nixes the Possibility of Costly M&As 10/23/2015
Shire (SHPG) Terminates Milestone Payments to Former Lumena Shareholders After Liver Drug Fails 10/23/2015
Dechra Pharmaceuticals PLC: Trading Update 10/23/2015
Merus Labs International Inc. Announces Filing of Audited June 30, 2015 Financial Statements 10/22/2015
Xizang Haisco Pharma Invests $10 Million In Endospan Of Israel 10/22/2015
Perrigo (PRGO) to Chop 800 Jobs, Buy Back Shares to Fend Off Mylan (MYL) 10/22/2015
Axxess Pharma, Inc. Completes And Submits Audited Financials To The Securities And Exchange Commission (SEC) For Up-Listing To The OTCQB Stock Exchange 10/21/2015
WuXi Healthcare Invests In US Genomics Testmaker 23andMe 10/21/2015
TPI Received Notice Of Non-Compliance With NYSE MKT Continued Listing Requirements 10/20/2015
WuXi PharmaTech (WX) Announces Extraordinary General Meeting Of Shareholders 10/20/2015
Livanova Begins Trading On NASDAQ And London Stock Exchange 10/19/2015
Hutchison China MediTech (Chi-Med) Files For US NASDAQ IPO 10/19/2015
Regeneus (RGS.AX) Annual Report 2015 To Shareholders 10/19/2015
Elekta Highlights Leading R&D Program And Reiterates Financial Ambitions 10/19/2015
IXICO plc Pre-Close Trading Update 10/19/2015
AEterna Zentaris (AEZS) Announces Special Meeting Of Shareholders And Mailing Of Management Information Circular 10/16/2015
Hutchison China MediTech (Chi-Med) Files Registration Statement For Potential Nasdaq Stock Market Listing 10/16/2015
NeuroVive (NVP): Annual General Meeting 2016 And Nomination Committee 10/16/2015
Valeant (VRX) Completes Tender Offer For Synergetics USA (SURG) 10/15/2015
Concordia Healthcare (CXR.TO) Provides Update On AMCo Financing And Capital Structure Post AMCo Acquisition 10/15/2015
Can-Fite BioPharma (CFBI) Announces $4.8 Million Registered Direct Offering 10/13/2015
Elbit Imaging Ltd. (EMITF) Announces Approval Of Notes Buyback Programs By The Company Totaling Up To NIS 50 Million 10/12/2015
LFB S.A. Increases Its Capital By 230 Million Euros 10/12/2015
Recipharm AB Announces Cost And Efficiency Program In Sweden 10/8/2015
Roche Holdings, Inc. Announces Final Results Of Its Debt Tender Offer 10/7/2015
Mallinckrodt (MNK) Provides Business Update Including Fiscal Year 2016 Financial Guidance Excluding Contrast Media And Delivery Systems (CMDS) And Ex-CMDS Historical Financial Information 10/6/2015
Skystar Bio-Pharmaceutical (CGPN) Provides Investor Update Regarding Delay In Filing Form 10-K 10/6/2015
JHL Biotech Lists On The Taiwan Emerging Stock Board 10/5/2015
Siegfried Successfully Places Public Hybrid Bond 10/2/2015
Amarantus BioSciences, Inc. Closes $5.5 Million Capital Infusion Through The Issuance Of A Combination Of Preferred Stock And Secured Debt Convertible 10/1/2015
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 9/30/2015
Onxeo: Publication Of A New Letter To Shareholders 9/30/2015
Karolinska Development AB Divests Its Holding In Xspray Microparticles To An Investment Consortium Led By Östersjöstiftelsen And Recipharm Venture Fund 9/29/2015
Takeda (TKPYY) Selected For The Sixth Consecutive Year For Dow Jones Sustainability Asia Pacific Index 9/29/2015
Sirona (SIRO) Announces Warrants Exercised 9/29/2015
Genovis is Reorganizing and Closing Its Subsidiary GeccoDots 9/25/2015
Serum Institute of India, Ltd. in Stake Sale Talks at $12 Billion Valuation 9/18/2015
Perrigo (PRGO) Rejects Unsolicited Mylan (MYL) Bid 9/17/2015
Aquinox (AQXP) Announces Closing Of $98.0 Million Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 9/16/2015
Telesta (TSX:TST) Publishes Its Annual Consolidated Financial Statements And Provides Corporate Updates 9/15/2015
Shire (SHPG) Mulls Ways to Sweeten Bid for Baxalta, Getting Cash to Baxalta Shareholders Faster 9/14/2015
Toshiba to Restructure After Scandal 9/9/2015
Mallinckrodt (MNK) Launches Notes Offering 9/9/2015
Deutsche Biotech Innovativ AG: First Berlin Starts Coverage With €67.90 Price Target 9/9/2015
Mindray Medical Announces Receipt Of Revised Non-Binding Proposal To Acquire The Company At US$27 Per ADS Or US$27 Per Ordinary Share 9/9/2015
Royal Philips Electronics N.V. (PHG)'s Big Mobile Health Play 9/8/2015
Mylan (MYL) To Launch Offer For Perrigo (PRGO) Directly To Perrigo Shareholders On Sept. 14 9/8/2015
Onxeo To Present At Investordagen 2015 The Largest Danish Private Investor Event 9/8/2015
Sectra (SECTB): Report From Sectra’s Annual General Meeting 2015 9/8/2015
Cortendo Announces Reverse Share Split 9/8/2015
BioTime (BTX) Announces Dual Listing On The Tel Aviv Stock Exchange 9/4/2015
Amarantus BioSciences, Inc. Announces Results Of Annual Meeting 9/3/2015
Letter To Orexo AB (ORXOF) Shareholders From CEO Nikolaj Sørensen 9/2/2015
Bulletin From Elekta AB (SE:EKTAB)’s Annual General Meeting 2015 9/1/2015
Amarantus BioSciences, Inc. Moves Annual Meeting Date Forward To September 2, 2015 8/27/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 8/26/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
DelMar Pharmaceuticals Completes $2.6 Million Registered Direct Offering 8/20/2015
Karolinska Development AB – Q2 Report - Invitation To Conference Call And Webcast 8/20/2015
Benitec (BLT.AX) Announces Pricing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/18/2015
AmpliPhi Biosciences Corporation (APHB) Announces Approval Of Common Stock Listing On NYSE MKT 8/18/2015
CRH Medical Announces Filing For A US Listing 8/17/2015
3SBio Inc. (SSRX) Selected As A Constituent Of The Hang Seng Composite LargeCap & MidCap Index 8/17/2015
Mylan (MYL) Lowers Acceptance Condition On Perrigo (PRGO) Offer To Greater Than 50% 8/13/2015
Portage Biotech's Biohaven Raises $ 4.1 Million In First Tranche Of Private Placement. Portage Invests $ 2.5 Million 8/11/2015
Sinovac Biotech Ltd. (SVA) Announces Results Of 2015 Annual General Meeting Of Shareholders 8/11/2015
VolitionRX Announces Second Quarter 2015 Financial Results And Business Update 8/11/2015
Concord Medical Services Holdings Limited (CCM) Announces Share Repurchase Program 8/10/2015
Amarantus BioSciences, Inc. Announces Adjournment Of Annual Meeting 8/10/2015
Mylan (MYL) Provides Update On Conditions To Perrigo (PRGO) Offer 8/5/2015
Amarantus BioSciences, Inc. Announces Adjournment Of Annual Meeting 8/4/2015
Lumenis (LUME) Announces Results Of Special Shareholders' Meeting 8/4/2015
AmpliPhi Biosciences Corporation (APHB) Cleared To Submit Listing Application To NYSE MKT 8/4/2015
China Cord Blood Corporation Files Its Annual Report On Form 20-F 8/3/2015
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) 8/3/2015
Change Of The Number Of Shares And Votes In Karo Bio AB 7/31/2015
Change In Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma) 7/31/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 7/31/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2015
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day 7/30/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 7/30/2015
Tissue Therapies Change In Strategy And Development Of Vitrogro As A Pharmaceutical Worldwide 7/28/2015
ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting 7/27/2015
Deutsche Biotech Innovativ AG: AGM Approves Bonus Shares And Capital Increase 7/24/2015
Allergy Therapeutics plc: Notice of Results and Trading Update 7/23/2015
Integrity Applications, Inc. Announces Adjournment Of Annual Meeting 7/23/2015
BioLight Announces Upcoming Change Of ADS Conversion Ratio 7/23/2015
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 7/22/2015
Horizon Pharma (HZNP) Increases Offer For Depomed (DEPO) To $33.00 Per Share 7/21/2015
NOVACYT Release: Strong First-Half Revenues Completes €3.5 Million In Bond Refinancing And Launches A €1.7 Million Private Placement 7/20/2015
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 7/17/2015
ProNAi Therapeutics, Inc. Announces Pricing Of Initial Public Offering 7/16/2015
NeuroDerm (NDRM) Announces Pricing Of Public Offering 7/16/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Size Of Proposed Public Offering Of Its American Depository Shares 7/15/2015
MediGene AG (MDGEF.PK): Notification § 27a 7/15/2015
Concordia Healthcare (CXR.TO) Announces Filing of Preliminary Base Shelf Prospectus 7/13/2015
Amarantus BioSciences, Inc. To Commence Trading On The OTCQX Marketplace Under Existing Ticker Symbol AMBS 7/13/2015
Merus Labs International Inc. Announces Filing of Preliminary Base Shelf Prospectus 7/10/2015
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market 7/9/2015
Karolinska Development AB Divests Its Holding In Pharmanest To An Investment Consortium Comprising Östersjöstiftelsen, Recipharm Venture Fund And Praktikerinvest 7/9/2015
Karolinska Development AB Implements A More Prudent And Representative Approach To Reporting The Fair Value Of Its Portfolio - Divestment Of Pharmanest 7/9/2015
Shareholders Support Management Proposals At SYGNIS ' AGM With Large Majority 7/9/2015
Resverlogix (RVX.TO) Closes License Agreement And Enters Into Definitive Stock Purchase Agreement With Shenzhen Hepalink Pharmaceutical Co., Ltd 7/8/2015



//-->